Cargando…

Reply to: “Reply: A dermatologic manifestation of COVID-19: Transient livedo reticularis”

Detalles Bibliográficos
Autores principales:	Manalo, Iviensan F., Smith, Molly K., Cheeley, Justin, Jacobs, Randy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2020
Materias:	JAAD Online
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204694/ https://www.ncbi.nlm.nih.gov/pubmed/32387668 http://dx.doi.org/10.1016/j.jaad.2020.05.001

Ejemplares similares

Reply to: “A dermatologic manifestation of COVID-19: Transient livedo reticularis”
por: Thomas, Cristina
Publicado: (2020)

A dermatologic manifestation of COVID-19: Transient livedo reticularis
por: Manalo, Iviensan F., et al.
Publicado: (2020)

Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic”
por: Kearns, Donovan G., et al.
Publicado: (2021)

Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection
por: Khalil, Shadi, et al.
Publicado: (2020)

Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020)

Reply to research letter
por: Rivera-Oyola, Ryan, et al.
Publicado: (2020)

Reply to the comment on “What are the barriers faced by underrepresented minorities applying to dermatology? A qualitative cross-sectional study of applicants applying to a large dermatology residency program”
por: Vasquez, Rebecca, et al.
Publicado: (2020)

Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020)

In response to: “Reply to research letter”
por: Wan, Marilyn T., et al.
Publicado: (2020)

Reply to comment on: The Gabrin sign
por: Wambier, Carlos Gustavo, et al.
Publicado: (2021)

Reply to “Varicella-like exanthem as a specific COVID-19–associated skin manifestation: multicenter case series of 22 patients”: Discussing specificity
por: Ortega-Quijano, Daniel, et al.
Publicado: (2020)

Reply to “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Schultz, Brittney, et al.
Publicado: (2021)

Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
por: Wambier, Carlos G.
Publicado: (2021)

Reply to: Comments on “Proposed approach for reusing surgical masks in COVID-19 pandemic”
por: Liu, Yuangang, et al.
Publicado: (2020)

Reply to early-onset effluvium secondary to COVID-19 and body hair effluvium
por: Wambier, Carlos Gustavo, et al.
Publicado: (2022)

Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Shakshouk, Hadir, et al.
Publicado: (2021)

Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
por: Peterson, Danielle, et al.
Publicado: (2020)

Livedo Reticularis Associated with COVID-19
por: Sahara, Toshinori, et al.
Publicado: (2021)

The oral cavity cannot be forgotten in the COVID-19 era: Is there a connection between dermatologic and oral manifestations?
por: Bemquerer, Larissa Marques, et al.
Publicado: (2021)

Dermatologic manifestations of hydroxychloroquine therapy: A closer look at the nails
por: Lipner, Shari R., et al.
Publicado: (2020)

Reply to: “Various forms of skin rash in COVID-19: Petechial rash in a patient with COVID-19 infection”
por: Joob, Beuy, et al.
Publicado: (2020)

Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”
por: Lebwohl, Mark, et al.
Publicado: (2020)

Reply to “Comment on ‘Current outbreak of monkeypox: essentials for the dermatologist’”
por: Khanna, Urmi, et al.
Publicado: (2022)

Comment on “The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries”
por: Baab, Kelsey, et al.
Publicado: (2021)

Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”
por: Pahalyants, Vartan, et al.
Publicado: (2022)

Response to: “Comment on ‘The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries’”
por: Freeman, Esther E., et al.
Publicado: (2021)

Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
por: Yousaf, Ahmed, et al.
Publicado: (2021)

Importance of nose wires in face masks: A reply to “Diagnostic and management considerations for “maskne” in the era of COVID-19”
por: Kassamali, Bina, et al.
Publicado: (2021)

Abdominal wall livedo reticularis
por: Shirahige, Tomoyuki, et al.
Publicado: (2023)

Reply to: Do interleukin 17 inhibitors increase risk of respiratory tract infections?
por: Blauvelt, Andrew, et al.
Publicado: (2020)

Reply to: “Do IL-17 inhibitors increase risk of respiratory tract infections?”
por: Wan, Marilyn T., et al.
Publicado: (2020)

COVID-19 and immunomodulator/immunosuppressant use in dermatology
por: Price, Kyla N., et al.
Publicado: (2020)

Dermatology practices as vectors for COVID-19 transmission: A call for immediate cessation of nonemergent dermatology visits
por: Kwatra, Shawn G., et al.
Publicado: (2020)

Reply to “Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients”: To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out
por: Llamas-Velasco, Mar, et al.
Publicado: (2020)

Reply to: “Skin damage among health care workers managing coronavirus disease 2019”
por: Maliyar, Khalad, et al.
Publicado: (2020)

Reply to: “Skin damage among health care workers managing coronavirus disease-2019”
por: Oranges, Teresa, et al.
Publicado: (2020)

Response to: “Reply to ‘Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients’: To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out”
por: Marzano, Angelo Valerio, et al.
Publicado: (2020)

COVID-19 compels closer scrutiny of disparities in dermatology
por: Temiz, Laurie A., et al.
Publicado: (2021)

Recommendations on dermatologic surgery during the COVID-19 pandemic
por: Der Sarkissian, Samuel Antranig, et al.
Publicado: (2020)

Reply to: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: A case series of 132 patients during the COVID-19 outbreak”
por: Ruggiero, Giuseppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3643t4n1odbmpk8djj90rjprte